Evidence map›Paper›PMID 37130041›Full record

ArticleTissue engineering. Part A2023

Magnetic and Biocompatible Polyurethane Nanofiber Biomaterial for Tissue Engineering.

Joshua A Choe, Susheil Uthamaraj, Dan Dragomir-Daescu, Gurpreet S Sandhu, Brandon J Tefft

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tissue engineering. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Magnetic Cell Targeting for Cardiovascular Tissue Engineering.Tissue engineering. Part B, Reviews · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joshua A ChoeDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Susheil UthamarajDivision of Engineering, Mayo Clinic, Rochester, Minnesota, USA.
Dan Dragomir-DaescuDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.
Gurpreet S SandhuDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Brandon J TefftDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-3687-7093

Funding

Nanotechnology for Magnetic Endothelialization of Implantable Cardiovascular DevicesR00HL129068 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI TEFFT, BRANDON J · 2018 to 2020
$737k
Nanotechnology for magnetic endothelialization of implantable cardiovascular devicesK99HL129068 · NHLBI · MAYO CLINIC ROCHESTER · PI TEFFT, BRANDON J · 2016 to 2017
$267k
NHLBI NIH HHS K99 HL129068NHLBI NIH HHS R00 HL129068
6 · The paper itself

Abstract

Recruitment of endothelial cells to cardiovascular device surfaces could solve issues of thrombosis, neointimal hyperplasia, and restenosis. Since current targeting strategies are often nonspecific, new technologies to allow for site-specific cell localization and capture

Indexed as

Biocompatible MaterialsNanofibersCoated Materials, BiocompatibleEndothelial CellsMagnetic PhenomenaPolyurethanesTissue EngineeringBiocompatible MaterialsCoated Materials, BiocompatiblePolyurethaneselectrospinningmagnetic biomaterialsmagnetic cell targetingnanofibersvascular stent-grafts

Identifiers

PMID37130041
PMCPMC10442687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.